Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 5:192:113645.
doi: 10.1016/j.jpba.2020.113645. Epub 2020 Sep 24.

Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids

Andrea Bonini  1 , Noemi Poma  2 , Federico Vivaldi  3 , Arno Kirchhain  2 , Pietro Salvo  4 , Daria Bottai  5 , Arianna Tavanti  5 , Fabio Di Francesco  2
Affiliations
Review

Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids

Andrea Bonini et al. J Pharm Biomed Anal. .

Abstract

A main challenge in the development of biosensing devices for the identification and quantification of nucleic acids is to avoid the amplification of the genetic material from the sample by polymerase chain reaction (PCR), which is at present necessary to enhance sensitivity and selectivity of assays. PCR has undoubtedly revolutionized genetic analyses, but it requires careful purification procedures that are not easily implemented in point of care (POC) devices. In recent years, a new strategy for nucleic acid detection based on clustered regularly interspaced short palindromic repeats (CRISPR) and associated protein systems (Cas) seems to offer unprecedented possibilities. The coupling of the CRISPR/Cas system with recent isothermal amplification methods is fostering the development of innovative optical and electrochemical POC devices. In this review, the mechanisms of action of several new CRISRP/Cas systems are reported together with their use in biosensing of nucleic acids.

Keywords: Biosensing; CRISPR/Cas; Electrochemical sensor; Molecular diagnostic; Nucleic acids; Optical sensor.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
CRISPR/Cas defense strategy (reprinted by [29] with permission of The American Association for the Advancement of Science).
Fig. 2
Fig. 2
Classification of Cas associated proteins (reprinted by [29] with permission of The American Association for the Advancement of Science).
Fig. 3
Fig. 3
PCR based molecular diagnostic workflow.
Fig. 4
Fig. 4
Biosensing strategy of: a) SHERLOK (reprinted by [62] with permission of The American Association for the Advancement of Science); b) DETECTR (reprinted by [63] with permission of The American Association for the Advancement of Science); c) HOLMES (freely repinted by [64]).
Fig. 5
Fig. 5
E-CRISPR detection strategy (reprinted by [74] with permission of Angewandte Chemie International Edition).
Fig. 6
Fig. 6
a) Schematic representation of microfluidic electrochemical biosensors. b) Mechanism of detection mediate by Cas13a. (freely repinted by [77]).
See this image and copyright information in PMC

References

    1. Hatoum-Aslan A. CRISPR methods for nucleic acid detection herald the future of molecular diagnostics. Clin. Chem. 2018;64:1681–1683. doi: 10.1373/clinchem.2018.295485. - DOI - PubMed
    1. Pickar-Oliver A., Gersbach C.A. The next generation of CRISPR–Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 2019;20:490–507. doi: 10.1038/s41580-019-0131-5. - DOI - PMC - PubMed
    1. Chen M., Calin G.A., Meng Q.H. 1st ed. Elsevier Inc.; 2014. Circulating microRNAs As Promising Tumor Biomarkers. - DOI - PubMed
    1. Finotti A., Fabbri E., Lampronti I., Gasparello J., Borgatti M., Gambari R. MicroRNAs and long non-coding RNAs in genetic diseases. Mol. Diagnosis Ther. 2019;23:155–171. doi: 10.1007/s40291-018-0380-6. - DOI - PMC - PubMed
    1. Kirchhain A., Poma N., Salvo P., Tedeschi L., Melai B., Vivaldi F., Bonini A., Franzini M., Caponi L., Tavanti A., Di Francesco F. Biosensors for measuring matrix metalloproteinases: an emerging research field. TrAC - Trends Anal. Chem. 2019;110 doi: 10.1016/j.trac.2018.10.027. - DOI

MeSH terms